Navigation Links
Making Your Way Through the Fog of Chemotherapy
Date:5/28/2010

Though accepted as real, 'chemo brain' still befuddles patients and researchers,,,,

FRIDAY, May 28 (HealthDay News) -- For many people with cancer, chemotherapy can be a lifeline to the future. And more aggressive, high-dose therapy has been shown to produce better results.

But there's a downside, too: Chemotherapy is linked to a mental fog called "chemo brain."

For years, people's complaints were dismissed as "all in your head," but that's no longer the case. It's now the topic of serious research, with investigators working hard to figure out why it happens and what can be done to help those who suffer from it.

Yet even with the added focus on chemo brain research, many doctors who care for cancer patients are either unaware of the phenomenon or don't think to discuss the possibility with their patients, said Saskia Subramanian, a research sociologist at the David Geffen School of Medicine at the University of California, Los Angeles, who has researched and published on chemo brain and wrote After the Cure: The Untold Stories of Breast Cancer Survivors.

She encourages patients to bring it up themselves, especially if they think they're experiencing it.

Among the symptoms:

  • Forgetting things that are usually easy to recall, such as names or words
  • Having problems concentrating
  • Having difficulty multi-tasking
  • Being slower at doing routine tasks

Exactly how many people develop chemo brain is unknown, agreed Subramanian and Christina Meyers, professor and chief of neuropsychology at the M.D. Anderson Cancer Center in Houston, who has researched the condition for more than two decades.

"I would say more than half of the cancer patients in active treatment have some kind of symptomology" related to chemotherapy, Meyers said. "It could range from pretty mild to so severe that a person is unable to perform their normal activities."

Subramanian said the estimates vary widely, from 20 or 30 percent to 90 percent of chemo patients. "My guess is it's somewhere in the middle," she said. "My suspicion is it has to do with how aggressive the treatment is."

Because the trend is toward more aggressive chemo, the pressure is on to learn more about the condition, what's behind it and how people can cope.

Researchers who've done studies involving imaging of the brain have found changes in the brain activity of breast cancer patients treated with chemotherapy, compared with those who didn't get chemo.

Meyers said that recent studies have also found acute injury to brain cells and damage to myelin, the white matter that coats nerve cells.

They are important clues, but much is still unknown about chemo brain. Even so, no one is suggesting that people opt out of chemo that is recommended to them, Subramanian noted. "It's not a reason to forego needed chemo," she said.

Some researchers are looking at medicines in use for such conditions as depression, attention-deficit/hyperactivity disorder and dementia to see if the drugs might help those with chemo brain. And research is also underway to develop animal models and come up with new drugs to counteract the effects of chemo brain, Meyers said.

But until then, she said, anyone having chemotherapy would be wise to develop compensatory measures. These could include:

  • Setting up a "memory station" at home -- one place to keep keys, important papers and work-related items you need to take to the office.
  • Using a day planner or personal digital assistant for reminders about meetings and appointments.
  • Using checklists. One might be a list of things to do when leaving work: Log off your network, turn off your computer, turn on voice mail, turn off the coffee pot, turn off the lights -- anything that needs to get done.
  • Parking in the same place at work, at the mall, wherever you go often.
  • Not trying to multi-task. Even if you were champion before, Meyers said, for now do just one task at a time.

Certain strategies, though, are not helpful, Meyers added. For instance, one thing that she said doesn't work is doing repetitive mental exercises, such as crossword puzzles or video games. She said many people with chemo brain tell her they try that, but she said it doesn't seem to translate to remembering names better.

Also, the experts agreed that anyone complaining of chemo brain ought to be evaluated to make sure that other problems -- such as depression or a thyroid problem -- aren't contributing to the fog and mental slowdown.

More information

The American Cancer Society has more on chemo brain.



SOURCES: Christina Meyers, Ph.D., professor and chief, section of neuropsychology, M.D. Anderson Cancer Center, Houston; Saskia Subramanian, Ph.D., research sociologist, department of psychology, David Geffen School of Medicine, University of California, Los Angeles; American Cancer Society (www.cancer.org)


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. New On-Q Pain Pump Making Tummy Tucks Easier
2. Dr. Alexander Rivkin's Pioneering Non-Surgical Nose and Eye Transformations Are Making Headlines and May Be Permanent Solutions
3. Rent for Ryder Cup 2010: Making Your Stay Memorable
4. New Book Reveals the Powerful and Undermining Impact of Stress on Good Decision Making and What Leaders Can Do About It
5. Is patient coding making hospitals appear better than they are?
6. San Diego Plastic Surgery Practice Making a Splash in United Kingdom and Australia
7. Love Making And Exercise Can Trigger Headache Pain?
8. Zerion Software Releases iPad Data Collection App, Making the iPad a Serious Business Tool
9. More than one-quarter of elderly patients lack decision-making capacity at death
10. Governor Tim Pawlenty Issues Proclamation Making Thursday, March 25, 2010 Medical Biller's Day
11. Irelands Allergy Standards Limited Adds LG Electronics to Host of Companies Making Allergy-Certified Consumer Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... , ... Are You Concerned About Mold In Your Home or Workplace? ... Companies in VA, MD and DC, recently completed its application for the new District ... in the district of Columbia is a good thing stated John Taylor, Owner of ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and Sara ... speak at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference ... Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & ...
(Date:12/2/2016)... Los Angeles, CA (PRWEB) , ... December 02, 2016 , ... For over twenty-four years, ... a lien basis to help personal injury victims find high quality medical care. When ... the Los Angeles area. Fast forward to present day and the now ten-page directory ...
(Date:12/2/2016)... ... December 02, 2016 , ... FlexiSpot, ... of its 60-day free trial program for all of the company’s desktop riser ... a truly hassle free experience. , FlexiSpot’s unique desktop risers use an advanced ...
(Date:12/2/2016)... New York, NY (PRWEB) , ... December 02, 2016 , ... ... Through an exclusive interview with Mediaplanet, Dr. Murthy explains how he was inspired to ... “Early on I learned that medicine is about more than making diagnoses and prescribing ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... -- Seno Medical Instruments, Inc., the company pioneering the development ... the process of diagnosing breast cancer, today announced that ... surveillance and clinical follow-up study at the 2016 ... from December 6-10, 2016 at the Henry B. Gonzalez ... . Seno Medical Instruments will present two ...
(Date:12/5/2016)... and TAIPEI, Taiwan , Dec. ... months of treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) ... a significantly better safety and tolerability profile of ropeginterferon alfa-2b ... from PROUD-PV and the ongoing long-term follow-up trial CONTINUATION-PV to ... PharmaEssentia intends to present this data to the FDA ...
(Date:12/4/2016)... 3, 2016 Sickle cell disease (SCD) is ... blood cells that get stuck in veins and block ... failure, and complications leading to death. Each year, approximately ... and most of them lack access to comprehensive care ... long-term therapy for SCD, a pill called hydroxyurea approved ...
Breaking Medicine Technology: